rules for prescribing Lamictal

If you’re managing bipolar disorder, you’ve probably wondered: Can I get my mood stabilizers through telehealth? The short answer is yes—but the details matter. As mental healthcare moves online, understanding the legal landscape for telehealth prescribing can help you access treatment confidently and safely.

This guide breaks down everything you need to know about getting bipolar medications like Lithium, Lamictal, and Seroquel prescribed through virtual visits, including federal rules, state-by-state differences, and what to expect from your telehealth provider.

Understanding Telehealth for Bipolar Disorder

Telehealth has transformed mental healthcare access, especially for conditions like bipolar disorder that require ongoing medication management. Unlike ADHD stimulants or anxiety medications (benzodiazepines), most bipolar medications fall into a legal category that makes telehealth prescribing straightforward.

Why Bipolar Medications Are Different

The key distinction: common mood stabilizers are not controlled substances. Medications like Lithium (lithium carbonate), Lamictal (lamotrigine), and Seroquel (quetiapine) are FDA-approved for bipolar disorder but aren’t classified as DEA-scheduled drugs. This matters because federal restrictions on telehealth prescribing primarily target controlled substances with abuse potential.

This legal classification means you won’t face the same regulatory hurdles as someone seeking stimulant medication for ADHD or benzodiazepines for anxiety. The process is more similar to getting antidepressants or blood pressure medication via telemedicine.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Laws: What You Need to Know

The Ryan Haight Act and Why It Doesn’t Apply

You may have heard about the Ryan Haight Act, a 2008 federal law requiring an in-person medical evaluation before prescribing controlled substances online. Here’s the critical point: this law only applies to DEA-scheduled medications.

Since Lithium, Lamictal, and Seroquel aren’t controlled substances, the Ryan Haight Act’s in-person requirement simply doesn’t apply. There’s no federal law preventing a qualified healthcare provider from prescribing these medications after a proper telehealth evaluation.

Current DEA Telehealth Flexibilities

For context on the broader telehealth landscape: the DEA extended COVID-era flexibilities for prescribing controlled substances via telehealth through December 31, 2026. While this primarily affects medications like Adderall or Xanax, it demonstrates the federal government’s continued support for telemedicine as a legitimate healthcare delivery model.

For bipolar medications specifically, these temporary extensions are less relevant—you don’t need special pandemic waivers because these drugs were always permissible to prescribe via telehealth under standard medical practice guidelines.

State-by-State Telehealth Rules

While federal law sets the baseline, individual states regulate the practice of medicine—including telehealth. The good news: every U.S. state permits telehealth prescribing of non-controlled mood stabilizers, though some have specific requirements.

States With No Special In-Person Requirements

Most states treat telehealth evaluations as equivalent to in-person visits when establishing a patient-provider relationship. This includes major states like:

California: Explicitly allows appropriate telehealth examinations to establish care. Recent legislation (AB 1503) may expand allowances for asynchronous screening tools, making initial evaluations even more accessible.

Texas: State law specifically permits mental health teleprescribing without requiring an in-person visit first. Texas had previously restricted telehealth for certain pain medications, but bipolar mood stabilizers face no such barriers.

New York: Telehealth evaluations are accepted for establishing care. Note that New York implemented new rules in 2025 requiring in-person visits for controlled substance prescriptions (with exceptions), but this doesn’t affect Lithium, Lamictal, or Seroquel.

Florida: No in-person requirement for non-controlled medications. Florida’s restrictions on Schedule II controlled substance prescribing via telehealth specifically exempt psychiatric treatment.

States With Periodic Check-In Requirements

New Hampshire stands out with a unique rule: if you’re receiving ongoing telehealth treatment, providers must conduct an evaluation at least once every 12 months. The good news? This annual check can be done via telehealth—it doesn’t have to be in-person. This requirement came from legislation (SB 252) passed in 2025 that actually expanded telehealth prescribing while adding this safety measure.

What ‘Telehealth Evaluation’ Actually Means

States generally require that telehealth visits meet the same ‘standard of care’ as in-person evaluations. This typically means:

• Real-time video interaction (not just phone or text)
• Informed consent for telehealth services
• Proper patient identification and verification
• Documentation of the encounter in your medical record
• Emergency protocols in place if urgent care becomes necessary

Some states mandate electronic prescribing (e-prescribing) for all medications, meaning your provider must use certified software to send prescriptions directly to your pharmacy rather than calling them in or providing paper scripts.

Which Healthcare Providers Can Prescribe

The type of provider who can prescribe your bipolar medication via telehealth depends on state scope-of-practice laws for nurse practitioners (NPs) and physician assistants (PAs).

Psychiatrists and Medical Doctors

Psychiatrists (MDs and DOs) can prescribe bipolar medications via telehealth in all 50 states, as long as they’re licensed in your state. This is the most straightforward pathway.

Nurse Practitioners: Growing Independence

As of 2025, over 30 states grant nurse practitioners full practice authority—meaning they can evaluate patients and prescribe medications independently without physician oversight. States with full NP practice authority include:

• New York
• Delaware
• New Hampshire
• Illinois (after meeting experience requirements)
• California (transitioning to full authority by 2026 under AB 890)

In states with collaborative practice requirements, NPs can still prescribe bipolar medications but must have a formal agreement with a supervising physician. These states include:

• Texas
• Florida
• Pennsylvania
• Georgia
• Alabama

Importantly, even in collaborative-practice states, NPs face fewer restrictions on non-controlled medications than on controlled substances. An NP working under a collaborative agreement can absolutely manage your bipolar disorder and prescribe Lithium or Lamictal—they just need that physician relationship in place.

Physician Assistants

PAs can prescribe medications in all states but generally require some level of physician supervision or collaborative agreement. The specifics vary by state, but PAs are qualified to manage bipolar disorder within their scope of practice.

Choosing the Right Provider

Platforms like Klarity Health carefully credential providers and ensure they’re licensed in your state and practicing within their legal scope. When you connect with a psychiatric provider through Klarity, you can trust they have the proper authority to evaluate and treat your condition—whether they’re a psychiatrist, psychiatric NP, or PA working within state guidelines.

The Three Most Common Bipolar Medications and Telehealth

Let’s look at the specific medications most frequently prescribed for bipolar disorder and how telehealth prescribing works for each.

Lithium (Lithium Carbonate)

DEA Status: Not scheduled (non-controlled)
Telehealth Prescribing: Legal in all 50 states
Typical Supply: 30-90 day fills with refills

Lithium is the gold-standard mood stabilizer for bipolar disorder, particularly effective for manic episodes and long-term mood maintenance. Because it’s not a controlled substance, there are no federal or state restrictions specifically on telehealth prescribing.

Clinical considerations: Your telehealth provider will need to order regular blood tests to monitor lithium levels, kidney function, and thyroid function. You’ll receive lab orders electronically and visit a local lab facility. Results are reviewed remotely, and your provider adjusts dosing as needed. This monitoring requirement is a medical standard of care, not a legal barrier to telehealth treatment.

Lamictal (Lamotrigine)

DEA Status: Not scheduled (non-controlled)
Telehealth Prescribing: Legal in all 50 states
Typical Supply: 30-90 day fills with refills

Lamotrigine is widely used for bipolar depression and mood stabilization, with a lower side effect profile than some alternatives. No legal restrictions limit telehealth prescribing.

Clinical considerations: Because Lamictal requires gradual dose titration to minimize rash risk, your provider may start with smaller supplies (2-week ‘starter packs’) before moving to standard 30-day fills. This is clinical prudence, not a legal requirement. Your telehealth provider will educate you on warning signs of serious rash and may schedule more frequent check-ins during the titration phase.

Seroquel (Quetiapine)

DEA Status: Not scheduled (non-controlled)
Telehealth Prescribing: Legal in all 50 states
Typical Supply: 30-90 day fills with refills

Quetiapine is an atypical antipsychotic approved for bipolar depression, acute mania, and maintenance treatment. Despite not being controlled, it has some potential for misuse, which leads to extra clinical scrutiny.

Clinical considerations: Some states include quetiapine in their Prescription Drug Monitoring Programs (PDMP) as a ‘drug of concern’ even though it’s not scheduled. Your provider may check the PDMP to review your prescription history as a safety measure. Metabolic monitoring (weight, blood sugar, lipids) is medically recommended, so expect your provider to order occasional lab work. Again, these are clinical best practices, not legal barriers to telehealth prescribing.

What to Expect: The Telehealth Prescribing Process

Understanding the typical flow of telehealth bipolar treatment helps set realistic expectations.

Initial Evaluation

Your first appointment will be comprehensive—often 45-60 minutes. The provider will:

• Review your mental health history and previous treatments
• Assess current symptoms using validated screening tools
• Evaluate for bipolar I vs. bipolar II vs. other mood disorders
• Rule out medical causes (thyroid problems, substance use, etc.)
• Discuss medication options, risks, and benefits
• Obtain informed consent for both telehealth treatment and the specific medication

This isn’t a ‘quick prescription’ visit. Legitimate telehealth providers take diagnosing and treating bipolar disorder seriously, following the same diagnostic criteria (DSM-5) as in-person psychiatrists.

Prescription and Pharmacy

If medication is appropriate, your provider will electronically prescribe to your preferred pharmacy (usually within hours of your visit). Because these are non-controlled medications, there are no unusual delays or special pharmacy requirements—you pick up your medication just like any other prescription.

Many providers will start with a 30-day supply for the first fill, then move to 90-day supplies once your dose is stable and you’ve demonstrated good response and adherence.

Follow-Up Schedule

Ongoing monitoring is essential for bipolar disorder. Expect:

• First month: Check-in at 2-4 weeks to assess response and side effects
• Second-third months: Monthly follow-ups during dose adjustments
• Stable phase: Every 3 months for medication management

These follow-ups can typically be done via telehealth (unless clinical concerns arise requiring in-person evaluation). You’ll also have lab work at intervals determined by your medication—particularly important for Lithium.

When In-Person Care Is Needed

Your telehealth provider may recommend in-person evaluation if:

• You’re experiencing severe mania or psychosis requiring potential hospitalization
• You have active suicidal thoughts or self-harm behaviors
• Lab results suggest medication toxicity or serious side effects
• Your symptoms aren’t responding to treatment and more intensive evaluation is needed

This is about clinical judgment, not legal restrictions. Responsible telehealth providers know when remote care is sufficient and when it isn’t.

Insurance, Pricing, and Access Through Klarity Health

One advantage of telehealth is often greater price transparency and flexibility.

Insurance Coverage

Most insurance plans now cover telehealth mental health visits at the same rate as in-person appointments. Klarity Health accepts many major insurance plans, and telehealth bipolar medication management is typically a covered service.

Cash-Pay Options

For those without insurance or preferring not to use it, Klarity offers transparent cash pricing. This can sometimes be more affordable than high-deductible insurance plans, and you’ll know the exact cost upfront—no surprise bills.

Provider Availability

A key advantage of telehealth: faster access to psychiatric care. Traditional psychiatry often has 2-3 month wait times for new patient appointments. Through platforms like Klarity, you can often be seen within days, not months. This is especially valuable for bipolar disorder, where timely treatment during mood episodes is critical.

Klarity’s network includes licensed psychiatric providers across multiple states, increasing your chances of finding an available appointment that fits your schedule—including evenings and weekends that traditional practices may not offer.

Common Myths and Concerns Addressed

‘Online psychiatrists can’t prescribe ‘real’ medications’

False. Telehealth psychiatrists and psychiatric NPs have the exact same prescribing authority as in-person providers (within their state’s scope of practice). They can prescribe the full range of bipolar medications—mood stabilizers, antipsychotics, and adjunctive treatments.

‘You’ll get medications without proper evaluation’

Not from legitimate providers. Reputable telehealth platforms like Klarity require comprehensive psychiatric evaluations, detailed medical histories, and appropriate documentation before prescribing. In fact, many patients report that their initial telehealth psychiatric evaluation was more thorough than rushed in-person appointments they’d experienced.

The misconception stems from a few bad actors in the telehealth space. In 2024, companies like Done and Cerebral faced legal action for allegedly prescribing controlled substances without adequate evaluation. These high-profile cases involved stimulants, not bipolar medications—but they highlight why choosing a reputable provider matters.

‘Mood stabilizers are narcotics or controlled drugs’

No. This common confusion arises because people hear ‘psychiatric medication’ and think ‘controlled substance.’ Lithium, Lamictal, and Seroquel are not narcotics, not controlled substances, and have no abuse potential recognized by the DEA. They’re in the same regulatory category as antidepressants—important medications but not subject to special restrictions.

‘Telehealth means lower quality care’

Not inherently. Quality depends on the provider and platform, not the delivery method. Studies show that telehealth mental health treatment can be equally effective as in-person care for many conditions, including mood disorders. The key is comprehensive evaluation, appropriate follow-up, and knowing when in-person care is needed.

Red Flags: How to Spot Problematic Telehealth Services

Protect yourself by watching for these warning signs:

🚩 Promises prescriptions before evaluation – Any service guaranteeing you’ll get a specific medication before you’ve even had an assessment is operating unethically.

🚩 Very short ‘consultations’ – A legitimate bipolar evaluation can’t be done in 5-10 minutes. If the provider seems to be rushing through, that’s concerning.

🚩 No discussion of monitoring or labs – Especially for Lithium, a provider who doesn’t mention blood work is cutting corners.

🚩 No follow-up plan – Bipolar disorder requires ongoing management. A ‘here’s your prescription, good luck’ approach is inadequate.

🚩 Vague about provider credentials – You should know exactly who your provider is, what their credentials are, and what state they’re licensed in.

🚩 Medication shipped directly without a pharmacy – Legitimate prescriptions go through licensed pharmacies where pharmacists review for safety and interactions.

Safety and Best Practices

For Patients Seeking Care

Be honest and thorough: Your provider can only help you if they have accurate information. Don’t downplay symptoms or leave out relevant history.

Keep appointments: Especially early in treatment, keeping your follow-up appointments is crucial for safety and effectiveness.

Report side effects promptly: Don’t wait until your next scheduled appointment if you’re experiencing concerning side effects. Most telehealth platforms offer messaging or urgent consultation options.

Get your labs done: If your provider orders blood work, complete it on time. This isn’t optional—it’s essential for safe medication management, especially with Lithium.

Have a local support system: Identify a local emergency resource (hospital, crisis center) in case of urgent needs. Your telehealth provider should ask about this.

For Providers

Telehealth prescribing of bipolar medications requires the same clinical rigor as in-person care:

• Comprehensive diagnostic evaluation following DSM-5 criteria
• Informed consent for both telehealth and medication
• Documentation that meets state standards and justifies the diagnosis and treatment
• Monitoring protocols appropriate to the medication (especially for Lithium)
• Safety planning including crisis resources and emergency contacts
• Clear boundaries on what can be managed remotely vs. what requires in-person care

The Future of Telehealth Prescribing

The legal landscape for telehealth continues to evolve. While the DEA’s temporary flexibilities for controlled substances are set to expire December 31, 2026 (pending permanent rulemaking), this doesn’t affect non-controlled bipolar medications.

Several federal bills propose codifying telehealth prescribing rules, but for mood stabilizers like Lithium, Lamictal, and Seroquel, the status quo is already favorable. These medications have always been legally prescribable via telehealth—and that’s unlikely to change.

State laws may continue to refine telehealth standards, but the trend is toward expansion of access, not restriction. The pandemic proved that high-quality mental healthcare can be delivered remotely for many patients, and both regulators and insurers have embraced this reality.

Is Telehealth Right for Your Bipolar Treatment?

Telehealth medication management works well for many people with bipolar disorder, particularly those who:

• Are relatively stable or experiencing mild-to-moderate mood symptoms
• Can access reliable video technology
• Have local resources for lab work
• Don’t require intensive monitoring or frequent in-person assessment
• Face barriers to traditional psychiatry (long wait times, transportation issues, geographic limitations)

It may not be the best fit if you’re currently experiencing:

• Severe mania or psychosis
• Active suicidal ideation or self-harm
• Symptoms requiring potential hospitalization
• Cognitive impairment that interferes with remote evaluation

The good news: you don’t have to decide alone. An initial telehealth consultation can help determine whether ongoing remote care is appropriate for your situation, or whether you’d benefit from in-person psychiatric services.

Getting Started With Telehealth for Bipolar Disorder

If you’re considering telehealth for bipolar medication management, here’s how to begin:

1. Choose a reputable platform
Research the telehealth provider. Look for established platforms with licensed psychiatric providers, clear pricing, and good patient reviews. Klarity Health offers access to board-certified psychiatrists and psychiatric nurse practitioners across multiple states, with both insurance and cash-pay options available.

2. Verify state licensure
Ensure the provider is licensed in your state. Legitimate platforms handle this automatically, but it’s worth confirming.

3. Prepare for your evaluation
Gather information about your mental health history, previous treatments and medications, current symptoms, and any relevant medical conditions. The more prepared you are, the more productive your initial visit will be.

4. Set up for success
Find a private, quiet space for your video appointment. Test your technology beforehand. Have your pharmacy information ready.

5. Commit to the process
Bipolar disorder management is a marathon, not a sprint. Be prepared for ongoing follow-up, monitoring, and dose adjustments as you and your provider work toward stability.

The bottom line: Getting bipolar medications like Lithium, Lamictal, and Seroquel via telehealth is legal, safe, and increasingly common across the United States. Federal law doesn’t restrict it, state laws generally permit it, and the standard of care remains high when you choose a reputable provider.

If you’ve been putting off seeking help for bipolar symptoms because of access barriers—long wait times, lack of local psychiatrists, or scheduling challenges—telehealth may be the solution you need. With the right provider, you can receive the same comprehensive psychiatric care remotely that you’d get in a traditional office setting, often with greater convenience and faster access.

Ready to explore telehealth treatment for bipolar disorder? Klarity Health connects you with licensed psychiatric providers who can evaluate your symptoms, discuss medication options, and develop a personalized treatment plan—all from the comfort and privacy of your home. With transparent pricing, insurance acceptance, and providers available across multiple states, getting the mental healthcare you deserve has never been more accessible.

References

1. U.S. Department of Health and Human Services. (2026, January 2). HHS & DEA Extend Telemedicine Flexibilities Through 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Drug Enforcement Administration. (2024, November 15). DEA and HHS Extend Telemedicine Flexibilities Through 2025. https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. Drug Enforcement Administration. (2025, December 31). DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care. https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care

4. Sheppard Mullin. (2017). Ryan Haight Act and Online Pharmacies. https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/

5. Sheppard Mullin. (2025, August 15). Telehealth and In-Person Visits: Tracking Federal and State Updates. https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,this%20flexibility%20has%20been%20prolonged
• https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/#:~:text=,Internet%20without%20a%20valid%20prescription
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=In%20late%202024%2C%20the%20U,V
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=person%20evaluation%20requirement%20under%20the,provide%20short%20term%20stability%20while
• https://www.ama-assn.org/health-care-advocacy/advocacy-update/jan-24-2025-national-advocacy-update#:~:text=telemedicine%20registrations%20for%20prescribing%20Schedule,Like%20the%20buprenorphine%20rule
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=The%20Fourth%20Temporary%20Extension%2C%20along,flexibilities%20under%20the%20fourth%20temporary
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,long%20as%20the%20issuing%20provider
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,a
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=5,a%20physician%20must%20generally%20use